Controlling Costs and Increasing Access to Prescription Drugs: State and Federal Solutions [PDF]
, 2002 Spending on health care in the United States continues to increase rapidly, consuming a greater share of the total economy each year. Over the past decade, prescription drug spending has been the fastest growing component of health care expenditures both
Michael Sullivan, Rebecca Kavoussi
core
Deep learning for drug repurposing: methods, databases, and applications [PDF]
arXiv, 2022 Drug development is time-consuming and expensive. Repurposing existing drugs for new therapies is an attractive solution that accelerates drug development at reduced experimental costs, specifically for Coronavirus Disease 2019 (COVID-19), an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
arxiv
Drug Legalization: The Importance of Asking the Right Question Symposium on Drug Decriminalization [PDF]
, 1989 As a policy analysis, this article\u27s central argument is that that the costs imposed by markets in licit psychoactives are significantly greater than those imposed by drug ...
Kleinman, Mark A.R., Saiger, Aaron J
core +1 more source
Cost-effectiveness of Methadone Maintenance Treatment in prevention of HIV among drug users in Shiraz, south of Iran [PDF]
, 2014 Background: The increase in high-risk injections and unsafe sexual behaviors has led to increased HIV infection prevalence among Intravenous Drug Users (IDUs). The high costs of HIV/AIDS care and low financial resources necessitate an economic evaluation
Heidari, A. +3 more
core +1 more source
Indian Heart Journal, 2021 Background: Costs can be a major barrier to medication adherence in low and middle-income countries and are an important target for policy-level interventions.
Balaji Arvind +3 more
doaj
Tri-graph Information Propagation for Polypharmacy Side Effect Prediction [PDF]
arXiv, 2020 The use of drug combinations often leads to polypharmacy side effects (POSE). A recent method formulates POSE prediction as a link prediction problem on a graph of drugs and proteins, and solves it with Graph Convolutional Networks (GCNs). However, due to the complex relationships in POSE, this method has high computational cost and memory demand. This
arxiv
Is It Possible to Have Cheaper Drugs and Preserve the Incentive to Innovate: Reforming the Drug Approval Process According to Market Principles [PDF]
This paper argues that drugs are expensive not because of a lack of competition among research-based pharmaceutical companies, but because of a lack of competition in the drug approval process.
Corinne Sauer, Robert Sauer
core
Urologic Cancer Drug Costs in Low- and Middle-Income Countries
Société Internationale d’Urologie JournalAll 189 World Bank member countries are classified by their capita gross national income into one of four income groups. In this review, we aim to explore the economic burden and management of urologic oncology conditions in low- and middle-income ...
Lan Anh S. Galloway +2 more
doaj +1 more source
Turning genome-wide association study findings into opportunities for drug repositioning [PDF]
arXiv, 2019 Drug development is a very costly and lengthy process, while repositioned or repurposed drugs could be brought into clinical practice within a shorter time-frame and at a much reduced cost. The past decade has observed a massive growth in the amount of data from genome-wide association studies (GWAS).
arxiv
Study of Drug Utilisation and Adverse Drug Reaction Pattern of Anti-glaucoma Drugs in Patients with Primary Open Angle Glaucoma Attending the Glaucoma Clinic at a Tertiary Care Institute in Bihar, India: A Cross-sectional Study [PDF]
Journal of Clinical and Diagnostic ResearchPrimary Open Angle Glaucoma (POAG) is a leading cause of secondary blindness, with pharmacotherapy being the mainstay of treatment. As guidelines and recommendations have evolved, so have prescribing trends.
Nitu Pandey +3 more
doaj +1 more source